Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?

Background. The prevalence of adrenal insufficiency (AI) in cystic fibrosis (CF) is unknown. The frequent use of glucocorticoids (inhaled or systemic) may induce the long-term suppression of the hypothalamic-pituitary-adrenal axis. Methods. We reviewed the results of adrenocorticotropic hormone (ACT...

Full description

Saved in:
Bibliographic Details
Main Authors: Sébastien Préville-Ratelle, Adèle Coriati, Aurélie Ménard, Isabelle Bourdeau, François Tremblay, Yves Berthiaume
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2018/3629031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546720020430848
author Sébastien Préville-Ratelle
Adèle Coriati
Aurélie Ménard
Isabelle Bourdeau
François Tremblay
Yves Berthiaume
author_facet Sébastien Préville-Ratelle
Adèle Coriati
Aurélie Ménard
Isabelle Bourdeau
François Tremblay
Yves Berthiaume
author_sort Sébastien Préville-Ratelle
collection DOAJ
description Background. The prevalence of adrenal insufficiency (AI) in cystic fibrosis (CF) is unknown. The frequent use of glucocorticoids (inhaled or systemic) may induce the long-term suppression of the hypothalamic-pituitary-adrenal axis. Methods. We reviewed the results of adrenocorticotropic hormone (ACTH) stimulation tests done over a 10-year period to evaluate adrenal function in 69 CF patients of the CHUM CF clinic. Clinical characteristics of AI patients were compared to adrenal-sufficient (AS) patients. Results. AI was confirmed in 33 of the 69 CF patients. A higher rate of dysglycemia P=0.022 and of Aspergillus positive culture P=0.006 was observed in AI patients compared to AS patients. Weight, CFTR genotype, and pulmonary function were comparable between AI and AS patients. The use of systemic corticosteroids (SC) prior to the diagnosis of AI was observed in 42.4% of patients. Compared to AI patients without SC, SC-treated AI patients were older and had a higher rate of allergic bronchopulmonary aspergillosis. Conclusion. This study is the first to systematically examine the presence of AI in the largest cohort of CF patients studied to date with a prevalence of 8%. Patients treated with corticosteroids and those colonized with Aspergillus have a greater risk of AI.
format Article
id doaj-art-2a03a33fe7864af88ecce7da6be74763
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-2a03a33fe7864af88ecce7da6be747632025-02-03T06:47:23ZengWileyCanadian Respiratory Journal1198-22411916-72452018-01-01201810.1155/2018/36290313629031Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?Sébastien Préville-Ratelle0Adèle Coriati1Aurélie Ménard2Isabelle Bourdeau3François Tremblay4Yves Berthiaume5Clinique de fibrose kystique, Centre hospitalier de l’Université de Montréal (CHUM), 1051 rue Sanguinet, Montréal, QC, H2X 0C1, CanadaInstitut de recherches cliniques de Montréal (IRCM), 110 Avenue des Pins, Montréal, QC, H2W 1R7, CanadaInstitut de recherches cliniques de Montréal (IRCM), 110 Avenue des Pins, Montréal, QC, H2W 1R7, CanadaCentre de recherche Centre hospitalier de l’Université de Montréal (CRCHUM), 900 rue Saint-Denis, Montréal, QC, H2X 0A9, CanadaClinique de fibrose kystique, Centre hospitalier de l’Université de Montréal (CHUM), 1051 rue Sanguinet, Montréal, QC, H2X 0C1, CanadaClinique de fibrose kystique, Centre hospitalier de l’Université de Montréal (CHUM), 1051 rue Sanguinet, Montréal, QC, H2X 0C1, CanadaBackground. The prevalence of adrenal insufficiency (AI) in cystic fibrosis (CF) is unknown. The frequent use of glucocorticoids (inhaled or systemic) may induce the long-term suppression of the hypothalamic-pituitary-adrenal axis. Methods. We reviewed the results of adrenocorticotropic hormone (ACTH) stimulation tests done over a 10-year period to evaluate adrenal function in 69 CF patients of the CHUM CF clinic. Clinical characteristics of AI patients were compared to adrenal-sufficient (AS) patients. Results. AI was confirmed in 33 of the 69 CF patients. A higher rate of dysglycemia P=0.022 and of Aspergillus positive culture P=0.006 was observed in AI patients compared to AS patients. Weight, CFTR genotype, and pulmonary function were comparable between AI and AS patients. The use of systemic corticosteroids (SC) prior to the diagnosis of AI was observed in 42.4% of patients. Compared to AI patients without SC, SC-treated AI patients were older and had a higher rate of allergic bronchopulmonary aspergillosis. Conclusion. This study is the first to systematically examine the presence of AI in the largest cohort of CF patients studied to date with a prevalence of 8%. Patients treated with corticosteroids and those colonized with Aspergillus have a greater risk of AI.http://dx.doi.org/10.1155/2018/3629031
spellingShingle Sébastien Préville-Ratelle
Adèle Coriati
Aurélie Ménard
Isabelle Bourdeau
François Tremblay
Yves Berthiaume
Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
Canadian Respiratory Journal
title Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
title_full Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
title_fullStr Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
title_full_unstemmed Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
title_short Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
title_sort adrenal insufficiency in cystic fibrosis a rare phenomenon
url http://dx.doi.org/10.1155/2018/3629031
work_keys_str_mv AT sebastienprevilleratelle adrenalinsufficiencyincysticfibrosisararephenomenon
AT adelecoriati adrenalinsufficiencyincysticfibrosisararephenomenon
AT aureliemenard adrenalinsufficiencyincysticfibrosisararephenomenon
AT isabellebourdeau adrenalinsufficiencyincysticfibrosisararephenomenon
AT francoistremblay adrenalinsufficiencyincysticfibrosisararephenomenon
AT yvesberthiaume adrenalinsufficiencyincysticfibrosisararephenomenon